CD80
4 abstracts
Abstract
Stimulator of interferon gene (STING) expression as a biomarker for overall survival in PDL1-negative, TMB-low non-small cell lung cancer (NSCLC) treated with immune checkpoint inhibitors (ICIs).Org: Caris Life Sciences Research and Development, Caris Life Sciences, Irving, TX, Montefiore Einstein Center for Cancer Care, Lombardi Comprehensive Cancer Center, Georgetown University, Stephenson Cancer Center, University of Oklahoma Health Sciences Center, Oklahoma City, OK,
Abstract
Transforming growth factor-b1 and soluble co-inhibitory immune checkpoints as putative drivers of immune suppression in advanced basal cell carcinoma.Org: University of Pretoria, Steve Biko Academic Hospital, The Medical Oncology Centre of Rosebank,
Abstract
Comprehensive profiling of clock genes expression in hepatocellular carcinoma (HCC).Org: Norris Comprehensive Cancer Center, Keck School of Medicine of the University of Southern California, University of Southern California Marshall School of Business, Caris Life Sciences, Irving, TX, Lawrence J. Ellison Institute for Transformative Medicine, Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California, Los Angeles, CA,
Abstract
Dysregulation of immune checkpoint proteins in patients with newly diagnosed early breast cancer undergoing neoadjuvant chemotherapy: A comparison between patients with triple negative breast cancer (TNBC) and non-TNBC.Org: The Medical Oncology Centre of Rosebank, Johannesburg, South Africa, Department of Immunology, Faculty of Health Science, University of Pretoria, Pretoria, South Africa, University of Pretoria, Department of Immunology, Pretoria, South Africa, Netcare, City of Johannesburg, South Africa, Drs Gritzman and Thatcher Inc. Pathology Laboratory, City of Johannesburg, South Africa,